SNDX Competitors & Alternatives
Compare Syndax Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
SNDX
Main Stock$20.09
Tradestie Score
59
Market Cap
$1.35B
Revenue Growth
2.2%
Analyst Upside
+95.4%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix, Inc.
|
$8.93
|
$1.92B | - | 61 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$130.38
|
$1.92B | - | 60 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$56.91
|
$1.90B | 348.8 | 58 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$35.02
|
$1.84B | - | 55 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.48
|
$1.81B | - | 50 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$4.09
|
$1.78B | - | 47 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$17.08
|
$1.78B | - | 57 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$16.46
|
$1.74B | - | 59 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$30.70
|
$1.68B | - | 54 | Compare |
|
MNKD
Mannkind Corporation
|
$3.06
|
$1.65B | - | 57 | Compare |
More SNDX Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry